Gerresheimer AG (GXI.DE) has a MoatMap StockRank of 29/100 based on Quality (38/100), Value (44/100), and Momentum (35/100) factor scores. The current signal is SELL. Gerresheimer AG has a low quality score in our screen and faces high energy input costs in Europe, offsetting its GLP-1 packaging tailwinds.
Gerresheimer AG manufactures specialty glass and plastic packaging solutions, such as vials, syringes, and drug delivery systems, for the global pharmaceutical industry. Its competitive advantage is protected by strict regulatory validation standards, high switching costs for pharmaceutical clients, and clean-room manufacturing. The company is an essential, highly integrated global partner to major biotech and pharmaceutical firms.
| Price | $30.49 |
| Market Cap | $1.1B |
| P/E (TTM) | 37.94 |
| P/E (Forward) | 9.68 |
| Price/Book | 0.64 |
| Return on Equity | 1.8% |
| Return on Invested Capital | 7.3% |
| Debt/Equity | 161.83 |
| Gross Margin | 26.9% |
| Operating Margin | 1.3% |
| Revenue Growth | 12.5% |
| Dividend Yield | 0.1% |
| Free Cash Flow | $-773M |
Gerresheimer AG operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Germany).